Precancerous lesions of the breast

Annals of Oncology

Volumn 17, Issue SUPPL. 10, 2006, Pages

  Costa, A ^a,b  

^a EUROPEAN SCHOOL OF ONCOLOGY   (Italy)

^b IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST RECONSTRUCTION; BREAST SURGERY; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; CLINICAL EXAMINATION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; GALACTOGRAPHY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; HISTOPATHOLOGY; HUMAN; MULTIMODALITY CANCER THERAPY; ONCOGENE; PAGET NIPPLE DISEASE; PAPILLOMATOSIS; PRECANCER; PRIORITY JOURNAL;

BREAST NEOPLASMS; FEMALE; HUMANS; PRECANCEROUS CONDITIONS;

EID: 33749637486     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl272     Document Type: Article

References (13)

1. Sewell CW. Pathology of high-risk breast lesions and ductal carcinoma in situ. Radiologic Clinics of North America 2004; 42: 821-830.
2. Jacobs TW, Connolly JL, Schnitt SJ. Non malignant lesions in breast core needle biopsies: To excise or not to excise? Am J Surg Pathol 2002; 26: 1095-1110.
3. Schreer I, Luttges J. Precursor lesions of invasive breast cancer. Eur J Radiol 2005; 54: 62-71.
4. Krishnamurthy S, Sneige N. Molecular and biologic markers of premalignant lesions of human breast. Adv Anatomic Pathol 2002; 9: 185-197.
5. Stoll BA. Premalignant breast lesions: Rote for biological markers in predicting progression to cancer. Eur J Cancer 1999; 35: 693-697.
6. Allred DC and Mohsin SK. Biological features of human premalignant breast disease. In Harris R (ed.): Diseases of the breast. Philadelphia: Lippincott Williams & Wilkins 2000.
7. Veronesi U, Maisonneuve P, Costa A et al. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women. Lancet 1998; 352: 93-97.
8. Veronesi U, Maisonneuve P, Sacchini V et al. Tamoxifen for breast cancer among hysterectomised women. Lancet 2002; 359: 1122-1124.
9. Rudland PS. Epithelial stem cells and their possibile role in the development of the normal and diseased breast. Hystol Hystopathol 1993; 8: 385-387.
10. Vacava P, Naccarato AG, Bocci G et al. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. J Pathol 2004; 204: 140-146.
11. Silverstein MJ, Laglos MD, Craig PH et al. A prognostic index for DCIS. Cancer 1996; 77: 2267.
12. Morrow M. Schnitt SJ. Harris JR. DCIS and microinvasive carcinoma in diseases of the breast. In Harris R (ed.): Diseases of the breast. Philadelphia: Lippincott Williams & Wilkins 2000.
13. Silverstein MJ, Lagios MD, Lewinsky BS et al. Breast irradiation is unnecessary for widely excised DCIS. Breast Cancer Res Treat 1997; 46: 23.